Sign In
Buy MDGL
$513.43
+0.550 (+0.107%)
At Close: Jun 23, 2026
Inventiva S A : Information financière du 1er semestre 2020 | Zone bourse
04:30pm, Monday, 06'th Jul 2020Information financière du 1er semestre 2020
04:30pm, Monday, 06'th Jul 2020
Trésorerie et équivalents de trésorerie à 52,2 M€ au 30 juin 2020
Daix (France), le 6 juillet 2020 - Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le déve
A la suite des effets plus importants que prévus concernant la réduction de la stéatose lors de l'étude de Phase IIb NATIVE dans la NASH, le...
Intercept Pharmaceuticals: Regulatory Snub Unsettles Liver Therapy Front-Runner
05:41am, Sunday, 05'th Jul 2020
The FDA decision has wiped out more than a third of Intercept’s market cap. Yet, the company remains the front runner in the NASH space. The current trading mul
Geode Capital Management LLC Increases Stock Position in Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)
07:32am, Friday, 03'rd Jul 2020
Geode Capital Management LLC lifted its holdings in shares of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) by 12.1% during the first quarter, according to its most recent 13F filing with the Securities
B.Riley FBR Sticks to Its Buy Rating for Spectrum Pharmaceuticals (SPPI) - Markets
11:52am, Thursday, 02'nd Jul 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Spectrum Pharmaceuticals (SPPI – Research Report) today and set a
89bio (ETNB) Receives a Buy from Oppenheimer - Markets
10:56am, Thursday, 02'nd Jul 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target
Tower Research Capital LLC TRC Increases Holdings in Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)
06:22am, Thursday, 02'nd Jul 2020
Tower Research Capital LLC TRC lifted its position in shares of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) by 477.1% during the 1st quarter, according to its most recent filing with the Securities and
ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
12:00am, Thursday, 02'nd Jul 2020
Regulatory News: ABIONYX Pharma (Paris:ABNX): Market: Euronext Paris, Compartment C ISIN code: FR0012616852 Date Number of shares outstanding Total vo
Should You Throw in the Towel on Intercept Pharmaceuticals After Its Big Setback? | The Motley Fool
11:02am, Wednesday, 01'st Jul 2020
An approval pathway for OCA in treating NASH still exists. But it appears to be a steeper path.
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Catasys (CATS
Entasis Therapeutics Holdings (ETTX) Receives a Buy from H.C. Wainwright - Markets
10:21am, Wednesday, 01'st Jul 2020
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Entasis Therapeutics Holdings (ETTX – Research Report) today and set
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA
Stocks to watch: Voda Idea, ONGC, Airtel, autos, HUL, JSPL, Future Grp stks
03:17am, Wednesday, 01'st Jul 2020
Here's a look at the top stocks that may remain in focus today
